Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore Karrison

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
BMC Cancer|January 4, 2022
Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatmentAri J Rosenberg, Evgeny Izumchenko, Alexander Pearson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicityCharles M Rudin, Wanqing Liu, Apurva Desai, et al.
Plos One|July 2, 2014
Absolute quantitation of Met using mass spectrometry for clinical application: assay precision, stability, and correlation with MET gene amplification in FFPE tumor tissueDaniel V T Catenacci, Wei-Li Liao, Sheeno Thyparambil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2021
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in MelanomaDaniel J Olson, Zeynep Eroglu, Bruce Brockstein, et al.
Anesthesia and Analgesia|February 25, 2022
Pilot Findings of Pharmacogenomics in Perioperative Care: Initial Results From the First Phase of the ImPreSS TrialTien M Truong, Jeffrey L Apfelbaum, Keith Danahey, et al.
Plos One|February 4, 2010
CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinasesYi-Hung Carol Tan, Soundararajan Krishnaswamy, Suvobroto Nandi, et al.
Annals of Surgical Oncology|January 6, 2022
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) LevelsAnkit Dhiman, Charles C Vining, Hunter D D Witmer, et al.
Plos One|July 12, 2013
The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic targetBenjamin D Ferguson, Ren Liu, Cleo E Rolle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2015
Clustering of Toxoplasma gondii Infections Within Families of Congenitally Infected InfantsDespina Contopoulos-Ioannidis, Kelsey M Wheeler, Raymund Ramirez, et al.
Carcinogenesis|March 30, 2020
Cooperation of genes in HPV16 E6/E7-dependent cervicovaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogensPaula Böttinger, Karin Schreiber, Elizabeth Hyjek, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
BMC Cancer|January 4, 2022
Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatmentAri J Rosenberg, Evgeny Izumchenko, Alexander Pearson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicityCharles M Rudin, Wanqing Liu, Apurva Desai, et al.
Plos One|July 2, 2014
Absolute quantitation of Met using mass spectrometry for clinical application: assay precision, stability, and correlation with MET gene amplification in FFPE tumor tissueDaniel V T Catenacci, Wei-Li Liao, Sheeno Thyparambil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2021
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in MelanomaDaniel J Olson, Zeynep Eroglu, Bruce Brockstein, et al.
Anesthesia and Analgesia|February 25, 2022
Pilot Findings of Pharmacogenomics in Perioperative Care: Initial Results From the First Phase of the ImPreSS TrialTien M Truong, Jeffrey L Apfelbaum, Keith Danahey, et al.
Plos One|February 4, 2010
CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinasesYi-Hung Carol Tan, Soundararajan Krishnaswamy, Suvobroto Nandi, et al.
Annals of Surgical Oncology|January 6, 2022
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) LevelsAnkit Dhiman, Charles C Vining, Hunter D D Witmer, et al.
Plos One|July 12, 2013
The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic targetBenjamin D Ferguson, Ren Liu, Cleo E Rolle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2015
Clustering of Toxoplasma gondii Infections Within Families of Congenitally Infected InfantsDespina Contopoulos-Ioannidis, Kelsey M Wheeler, Raymund Ramirez, et al.
Carcinogenesis|March 30, 2020
Cooperation of genes in HPV16 E6/E7-dependent cervicovaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogensPaula Böttinger, Karin Schreiber, Elizabeth Hyjek, et al.
Pageof 16